Expression, sorting and transport studies for the orphan carrier SLC10A4 in neuronal and non-neuronal cell lines and in Xenopus laevis oocytes

BMC Neuroscience

Joachim Geyer¹  Simone Burger¹  Marcela Moncada¹  Stephanie Schmidt¹ 

[1] Institute of Pharmacology and Toxicology, Justus Liebig University of Giessen, Schubertstr. 81, Giessen, 35392, Germany

关键词: Sorting;    Neurotransmitter;    NTCP;    Transport;    SLC10A4;   

Others  :  1220315
DOI  :  10.1186/s12868-015-0174-2

 received in 2015-01-28, accepted in 2015-06-05,  发布年份 2015

【 摘 要 】

Background

SLC10A4 belongs to the solute carrier family SLC10 whose founding members are the Na ⁺ /taurocholate co-transporting polypeptide (NTCP, SLC10A1) and the apical sodium-dependent bile acid transporter (ASBT, SLC10A2). These carriers maintain the enterohepatic circulation of bile acids between the liver and the gut. SLC10A4 was identified as a novel member of the SLC10 carrier family with the highest phylogenetic relationship to NTCP. The SLC10A4 protein was detected in synaptic vesicles of cholinergic and monoaminergic neurons of the peripheral and central nervous system, suggesting a transport function for any kind of neurotransmitter. Therefore, in the present study, we performed systematic transport screenings for SLC10A4 and also aimed to identify the vesicular sorting domain of the SLC10A4 protein.

Results

We detected a vesicle-like expression pattern of the SLC10A4 protein in the neuronal cell lines SH-SY5Y and CAD. Differentiation of these cells to the neuronal phenotype altered neither SLC10A4 gene expression nor its vesicular expression pattern. Functional transport studies with different neurotransmitters, bile acids and steroid sulfates were performed in SLC10A4-transfected HEK293 cells, SLC10A4-transfected CAD cells and in Xenopus laevis oocytes. For these studies, transport by the dopamine transporter DAT, the serotonin transporter SERT, the choline transporter CHT1, the vesicular monoamine transporter VMAT2, the organic cation transporter Oct1, and NTCP were used as positive control. SLC10A4 failed to show transport activity for dopamine, serotonin, norepinephrine, histamine, acetylcholine, choline, acetate, aspartate, glutamate, gamma-aminobutyric acid, pregnenolone sulfate, dehydroepiandrosterone sulfate, estrone-3-sulfate, and adenosine triphosphate, at least in the transport assays used. When the C-terminus of SLC10A4 was replaced by the homologous sequence of NTCP, the SLC10A4-NTCP chimeric protein revealed clear plasma membrane expression in CAD and HEK293 cells. But this chimera also did not show any transport activity, even when the N-terminal domain of SLC10A4 was deleted by mutagenesis.

Conclusions

Although different kinds of assays were used to screen for transport function, SLC10A4 failed to show transport activity for a series of neurotransmitters and neuromodulators, indicating that SLC10A4 does not seem to represent a typical neurotransmitter transporter such as DAT, SERT, CHT1 or VMAT2.

【 授权许可】

   
2015 Schmidt et al.

【 图 表 】

Figure1.

Figure2.

Figure3.

Figure4.

Figure5.

Figure6.

【 参考文献 】

• [1]Geyer J, Wilke T, Petzinger E: The solute carrier family SLC10: more than a family of bile acid transporters regarding function and phylogenetic relationships. Naunyn Schmiedebergs Arch Pharmacol 2006, 372(6):413-431.
• [2]Döring B, Lütteke T, Geyer J, Petzinger E: The SLC10 carrier family: transport functions and molecular structure. Curr Top Membr 2012, 70:105-168.
• [3]Geyer J, Döring B, Meerkamp K, Ugele B, Bakhiya N, Fernandes CF, et al.: Cloning and functional characterization of human sodium-dependent organic anion transporter (SLC10A6). J Biol Chem 2007, 282(27):19728-19741.
• [4]Fietz D, Bakhaus K, Wapelhorst B, Grosser G, Günther S, Alber J, et al.: Membrane transporters for sulfated steroids in the human testis-cellular localization, expression pattern and functional analysis. PLoS One 2013, 8(5):e62638.
• [5]Grosser G, Fietz D, Günther S, Bakhaus K, Schweigmann H, Ugele B, et al.: Cloning and functional characterization of the mouse sodium-dependent organic anion transporter Soat (Slc10a6). J Steroid Biochem Mol Biol 2013, 138:90-99.
• [6]Splinter PL, Lazaridis KN, Dawson PA, LaRusso NF: Cloning and expression of SLC10A4, a putative organic anion transport protein. World J Gastroenterol 2006, 12(42):6797-6805.
• [7]Fernandes CF, Godoy JR, Döring B, Cavalcanti MC, Bergmann M, Petzinger E, et al.: The novel putative bile acid transporter SLC10A5 is highly expressed in liver and kidney. Biochem Biophys Res Commun 2007, 361(1):26-32.
• [8]Godoy JR, Fernandes C, Döring B, Beuerlein K, Petzinger E, Geyer J: Molecular and phylogenetic characterization of a novel putative membrane transporter (SLC10A7), conserved in vertebrates and bacteria. Eur J Cell Biol 2007, 86(8):445-460.
• [9]Visser WE, Wong WS, van Mullem AAA, Friesema ECH, Geyer J, Visser TJ: Study of the transport of thyroid hormone by transporters of the SLC10 family. Mol Cell Endocrinol 2010, 315(1–2):138-145.
• [10]Bijsmans ITGW, Bouwmeester RAM, Geyer J, Faber KN, van de Graaf SFJ: Homo- and hetero-dimeric architecture of the human liver Na + -dependent taurocholate co-transporting protein. Biochem J 2012, 441(3):1007-1015.
• [11]Jiang L, Alber J, Wang J, Du W, Yang X, Li X, et al.: The Candida albicans plasma membrane protein Rch1p, a member of the vertebrate SLC10 carrier family, is a novel regulator of cytosolic Ca 2+ homoeostasis. Biochem J 2012, 444(3):497-502.
• [12]Alber J, Jiang L, Geyer J: CaRch1p does not functionally interact with the high-affinity Ca 2+ influx system (HACS) of Candida albicans. Yeast 2013, 30(11):449-457.
• [13]Geyer J, Fernandes CF, Döring B, Burger S, Godoy JR, Rafalzik S, et al.: Cloning and molecular characterization of the orphan carrier protein Slc10a4: expression in cholinergic neurons of the rat central nervous system. Neuroscience 2008, 152:990-1005.
• [14]Burger S, Döring B, Hardt M, Beuerlein K, Gerstberger R, Geyer J: Co-expression studies of the orphan carrier protein Slc10a4 and the vesicular carriers VAChT and VMAT2 in the rat central and peripheral nervous system. Neuroscience 2011, 193:109-121.
• [15]Larhammar M, Patra K, Blunder M, Emilsson L, Peuckert C, Arvidsson E, et al.: SLC10A4 Is a vesicular amine-associated transporter modulating dopamine homeostasis. Biol Psychiatr 2014, 77:526-536.
• [16]Zelano J, Mikulovic S, Patra K, Kühnemund M, Larhammar M, Emilsson L, et al.: The synaptic protein encoded by the gene Slc10A4 suppresses epileptiform activity and regulates sensitivity to cholinergic chemoconvulsants. Exp Neurol 2013, 239:73-81.
• [17]Patra K, Lyons DJ, Bauer P, Hilscher MM, Sharma S, Leão RN, et al.: A role for solute carrier family 10 member 4, or vesicular aminergic-associated transporter, in structural remodelling and transmitter release at the mouse neuromuscular junction. Eur J Neurosci 2014, 41:316-327.
• [18]Abe T, Kanemitu Y, Nakasone M, Kawahata I, Yamakuni T, Nakajima A, et al.: SLC10A4 is a protease-activated transporter that transports bile acids. J Biochem 2013, 154(1):93-101.
• [19]Gómez-Santos C, Ambrosio S, Ventura F, Ferrer I, Reiriz J: TGF-β1 increases tyrosine hydroxylase expression by a mechanism blocked by BMP-2 in human neuroblastoma SH-SY5Y cells. Brain Res 2002, 958(1):152-160.
• [20]Kohr D, Tschernatsch M, Schmitz K, Singh P, Kaps M, Schäfer KH, et al.: Autoantibodies in complex regional pain syndrome bind to a differentiation-dependent neuronal surface autoantigen. Pain 2009, 143(3):246-251.
• [21]Qi Y, Wang JK, McMillian M, Chikaraishi DM: Characterization of a CNS cell line, CAD, in which morphological differentiation is initiated by serum deprivation. J Neurosci 1997, 17(4):1217-1225.
• [22]Geyer J, Godoy JR, Petzinger E: Identification of a sodium-dependent organic anion transporter from rat adrenal gland. Biochem Biophys Res Commun. 2004, 316(2):300-306.
• [23]Erickson JD, Eiden LE, Hoffman BJ: Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc Natl Acad Sci USA 1992, 89(22):10993-10997.
• [24]Rupprecht R: The neuropsychopharmacological potential of neuroactive steroids. J Psychiatr Res 1997, 31(3):297-314.
• [25]Reddy DS: Pharmacology of endogenous neuroactive steroids. Crit Rev Neurobiol 2003, 15(3–4):197-234.
• [26]Zheng P: Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance. Prog Neurobiol 2009, 89(2):134-152.
• [27]Jiang Y, Wu J, Hua Y, Keep RF, Xiang J, Hoff JT, et al.: Thrombin-receptor activation and thrombin-induced brain tolerance. J Cereb Blood Flow Metab 2002, 22(4):404-410.
• [28]Goldberg AA, Beach A, Davies GF, Harkness TAA, Leblanc A, Titorenko VI: Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells. Oncotarget 2011, 2(10):761-782.
• [29]Sun AQ, Arrese MA, Zeng L, Swaby I, Zhou MM, Suchy FJ: The rat liver Na + /bile acid cotransporter. Importance of the cytoplasmic tail to function and plasma membrane targeting. J Biol Chem 2001, 276(9):6825-6833.
• [30]Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193(1):265-275.